Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNYNF) Other Non Operating Income (2016 - 2018)

Historic Other Non Operating Income for Sanofi (SNYNF) over the last 6 years, with Q4 2018 value amounting to -$239.7 million.

  • Sanofi's Other Non Operating Income fell 14690.62% to -$239.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$777.8 million, marking a year-over-year increase of 3487.19%. This contributed to the annual value of -$212.6 million for FY2016, which is N/A changed from last year.
  • Latest data reveals that Sanofi reported Other Non Operating Income of -$239.7 million as of Q4 2018, which was down 14690.62% from $511.0 million recorded in Q4 2017.
  • Sanofi's Other Non Operating Income's 5-year high stood at $511.0 million during Q4 2017, with a 5-year trough of -$841.8 million in Q4 2015.
  • Moreover, its 5-year median value for Other Non Operating Income was -$239.7 million (2018), whereas its average is -$286.8 million.
  • In the last 5 years, Sanofi's Other Non Operating Income tumbled by 23579.89% in 2014 and then skyrocketed by 34649.71% in 2017.
  • Over the past 5 years, Sanofi's Other Non Operating Income (Quarter) stood at -$656.2 million in 2014, then decreased by 28.29% to -$841.8 million in 2015, then skyrocketed by 75.37% to -$207.3 million in 2016, then skyrocketed by 346.5% to $511.0 million in 2017, then tumbled by 146.91% to -$239.7 million in 2018.
  • Its last three reported values are -$239.7 million in Q4 2018, $511.0 million for Q4 2017, and -$207.3 million during Q4 2016.